Yasmeen Rahimi
Stock Analyst at Piper Sandler
(4.23)
# 463
Out of 4,996 analysts
86
Total ratings
45.78%
Success rate
19.76%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TRML Tourmaline Bio | Downgrades: Neutral | $65 → $48 | $47.74 | +0.54% | 2 | Sep 11, 2025 | |
| TENX Tenax Therapeutics | Initiates: Overweight | $20 | $7.26 | +175.48% | 1 | Sep 8, 2025 | |
| PRTA Prothena Corporation | Maintains: Overweight | $81 → $15 | $9.41 | +59.40% | 4 | Aug 28, 2025 | |
| IVA Inventiva | Initiates: Overweight | $26 | $6.05 | +329.75% | 1 | Aug 27, 2025 | |
| PLRX Pliant Therapeutics | Maintains: Overweight | $17 → $4 | $1.52 | +163.16% | 2 | Aug 8, 2025 | |
| VRNA Verona Pharma | Maintains: Overweight | $76 → $160 | $106.69 | +49.97% | 3 | Jun 23, 2025 | |
| TVRD Tvardi Therapeutics | Initiates: Overweight | $78 | $36.32 | +114.76% | 1 | Jun 12, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Overweight | $93 → $145 | $64.96 | +123.21% | 2 | Apr 24, 2025 | |
| EWTX Edgewise Therapeutics | Maintains: Overweight | $51 | $16.05 | +217.76% | 4 | Apr 2, 2025 | |
| LXRX Lexicon Pharmaceuticals | Maintains: Overweight | $10 → $6 | $1.40 | +328.57% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $48 | $10.80 | +344.44% | 1 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $93 | $52.72 | +76.40% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $75 | $17.26 | +334.53% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $105 | $58.50 | +79.49% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $37 | $28.50 | +29.82% | 2 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 | $2.41 | +978.84% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $0.94 | +2,881.58% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 | $45.91 | +111.28% | 4 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $270 | $52.02 | +419.03% | 3 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $15.20 | +400.00% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $4.00 | +525.00% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $13.51 | +122.06% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $6.56 | +82.93% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $4.02 | +2,138.81% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 | $40.66 | +342.70% | 2 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $2.70 | +455.56% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $336 | $424.23 | -20.80% | 3 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $3.52 | +354.55% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $23.58 | +239.27% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $25.00 | +272.00% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $16.23 | +251.20% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $7.34 | +812.81% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $67.42 | -48.09% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $7.90 | +1,001.27% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $9.79 | +1,687.54% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $50.40 | +42.86% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $54 → $19 | $14.70 | +29.25% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $2.98 | +1,577.85% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $1.66 | +2,309.64% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.37 | +4,801.43% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $420 | $16.00 | +2,525.00% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $22.17 | +247.32% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $72.76 | +5.83% | 1 | Jul 31, 2020 |
Tourmaline Bio
Sep 11, 2025
Downgrades: Neutral
Price Target: $65 → $48
Current: $47.74
Upside: +0.54%
Tenax Therapeutics
Sep 8, 2025
Initiates: Overweight
Price Target: $20
Current: $7.26
Upside: +175.48%
Prothena Corporation
Aug 28, 2025
Maintains: Overweight
Price Target: $81 → $15
Current: $9.41
Upside: +59.40%
Inventiva
Aug 27, 2025
Initiates: Overweight
Price Target: $26
Current: $6.05
Upside: +329.75%
Pliant Therapeutics
Aug 8, 2025
Maintains: Overweight
Price Target: $17 → $4
Current: $1.52
Upside: +163.16%
Verona Pharma
Jun 23, 2025
Maintains: Overweight
Price Target: $76 → $160
Current: $106.69
Upside: +49.97%
Tvardi Therapeutics
Jun 12, 2025
Initiates: Overweight
Price Target: $78
Current: $36.32
Upside: +114.76%
Soleno Therapeutics
Apr 24, 2025
Maintains: Overweight
Price Target: $93 → $145
Current: $64.96
Upside: +123.21%
Edgewise Therapeutics
Apr 2, 2025
Maintains: Overweight
Price Target: $51
Current: $16.05
Upside: +217.76%
Lexicon Pharmaceuticals
Mar 7, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $1.40
Upside: +328.57%
Feb 28, 2025
Initiates: Overweight
Price Target: $48
Current: $10.80
Upside: +344.44%
Jan 23, 2025
Initiates: Overweight
Price Target: $93
Current: $52.72
Upside: +76.40%
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $17.26
Upside: +334.53%
Nov 4, 2024
Initiates: Overweight
Price Target: $105
Current: $58.50
Upside: +79.49%
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $28.50
Upside: +29.82%
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $2.41
Upside: +978.84%
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $0.94
Upside: +2,881.58%
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $45.91
Upside: +111.28%
Jul 1, 2024
Maintains: Overweight
Price Target: $270
Current: $52.02
Upside: +419.03%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $15.20
Upside: +400.00%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $4.00
Upside: +525.00%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $13.51
Upside: +122.06%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $6.56
Upside: +82.93%
Apr 4, 2024
Initiates: Overweight
Price Target: $90
Current: $4.02
Upside: +2,138.81%
Mar 27, 2024
Maintains: Overweight
Price Target: $180
Current: $40.66
Upside: +342.70%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $2.70
Upside: +455.56%
Mar 14, 2024
Reiterates: Overweight
Price Target: $336
Current: $424.23
Upside: -20.80%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $3.52
Upside: +354.55%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $23.58
Upside: +239.27%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $25.00
Upside: +272.00%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $16.23
Upside: +251.20%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $7.34
Upside: +812.81%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $67.42
Upside: -48.09%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $7.90
Upside: +1,001.27%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $9.79
Upside: +1,687.54%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $50.40
Upside: +42.86%
May 18, 2022
Maintains: Overweight
Price Target: $54 → $19
Current: $14.70
Upside: +29.25%
Nov 15, 2021
Initiates: Overweight
Price Target: $50
Current: $2.98
Upside: +1,577.85%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $1.66
Upside: +2,309.64%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.37
Upside: +4,801.43%
Aug 26, 2020
Initiates: Overweight
Price Target: $420
Current: $16.00
Upside: +2,525.00%
Aug 26, 2020
Initiates: Overweight
Price Target: $77
Current: $22.17
Upside: +247.32%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $72.76
Upside: +5.83%